• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Compliance Concerns: Laboratory Regulations in 2024 and Beyond

Compliance Concerns: Laboratory Regulations in 2024 and Beyond

by Michael Schubert, PhD | Jan 7, 2025 | CLIA-lca, CMS-lca, Compliance Perspectives-lca, Compliance-lca, Essential, Lab Industry Advisor, Legislation-lca

Earle S. Collum, chair of the CAP Council on Accreditation, talks through regulatory changes in 2024 and what to expect from 2025

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Digital Pathology and AI: Now and in 2025

Digital Pathology and AI: Now and in 2025

by Michael Schubert, PhD | Dec 18, 2024 | Essential, Industry Buzz-lir, Lab Industry Advisor

Experts Nathan Buchbinder and Julianna Ianni discuss digital pathology and AI trends in 2024—and what the next year may hold

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: More than $62 Million Invested in Startup Labs in Recent Weeks

Dx Deals: More than $62 Million Invested in Startup Labs in Recent Weeks

by Ron Shinkman | Oct 1, 2024 | Deals-lir, Essential, Lab Industry Advisor

The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: FDA Moves Slowly on AI-Driven Lab Devices

FDA Watch: FDA Moves Slowly on AI-Driven Lab Devices

by Ron Shinkman | Sep 25, 2024 | Essential, FDA-lir, Lab Industry Advisor

The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The First Steps to Implementing Digital Pathology and AI

The First Steps to Implementing Digital Pathology and AI

by Michael Schubert, PhD | Sep 23, 2024 | Essential, Inside the Lab Industry-lir, Lab Industry Advisor

A guide to understanding, implementing, and benefiting from digital pathology and artificial intelligence in the clinical lab

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com